Table 3:
CTA (Richman et al. [18]) cases/total %(95% CI) | MRA This study cases/total % (95% CI) | p-value | |
---|---|---|---|
Type 1 (Actionable findings) | 160/921 17% (15–20%) |
85/514 17% (14–20%) |
0.5 |
Types 2 and 3 (Non-actionable findings or normal) |
761/921 83% (80–85%) |
429/514 83% (80–86%) |
0.5 |